Literature DB >> 22003108

Complement factor D in age-related macular degeneration.

Chloe M Stanton1, John R W Yates, Anneke I den Hollander, Johanna M Seddon, Anand Swaroop, Dwight Stambolian, Sascha Fauser, Carel Hoyng, Yi Yu, Kanda Atsuhiro, Kari Branham, Mohammad Othman, Wei Chen, Elod Kortvely, Kevin Chalmers, Caroline Hayward, Anthony T Moore, Baljean Dhillon, Marius Ueffing, Alan F Wright.   

Abstract

PURPOSE: To examine the role of complement factor D (CFD) in age-related macular degeneration (AMD) by analysis of genetic association, copy number variation, and plasma CFD concentrations.
METHODS: Single nucleotide polymorphisms (SNPs) in the CFD gene were genotyped and the results analyzed by binary logistic regression. CFD gene copy number was analyzed by gene copy number assay. Plasma CFD was measured by an enzyme-linked immunosorbent assay.
RESULTS: Genetic association was found between CFD gene SNP rs3826945 and AMD (odds ratio 1.44; P = 0.028) in a small discovery case-control series (462 cases and 325 controls) and replicated in a combined cohorts meta-analysis of 4765 cases and 2693 controls, with an odds ratio of 1.11 (P = 0.032), with the association almost confined to females. Copy number variation in the CFD gene was identified in 13 out of 640 samples examined but there was no difference in frequency between AMD cases (1.3%) and controls (2.7%). Plasma CFD concentration was measured in 751 AMD cases and 474 controls and found to be elevated in AMD cases (P = 0.00025). The odds ratio for those in the highest versus lowest quartile for plasma CFD was 1.81. The difference in plasma CFD was again almost confined to females.
CONCLUSIONS: CFD regulates activation of the alternative complement pathway, which is implicated in AMD pathogenesis. The authors found evidence for genetic association between a CFD gene SNP and AMD and a significant increase in plasma CFD concentration in AMD cases compared with controls, consistent with a role for CFD in AMD pathogenesis.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22003108      PMCID: PMC3230905          DOI: 10.1167/iovs.11-7933

Source DB:  PubMed          Journal:  Invest Ophthalmol Vis Sci        ISSN: 0146-0404            Impact factor:   4.799


  32 in total

Review 1.  Risk factors for age-related macular degeneration.

Authors:  J R Evans
Journal:  Prog Retin Eye Res       Date:  2001-03       Impact factor: 21.198

Review 2.  Extrahepatic complement biosynthesis: where, when and why?

Authors:  B P Morgan; P Gasque
Journal:  Clin Exp Immunol       Date:  1997-01       Impact factor: 4.330

3.  Genome-wide association study of advanced age-related macular degeneration identifies a role of the hepatic lipase gene (LIPC).

Authors:  Benjamin M Neale; Jesen Fagerness; Robyn Reynolds; Lucia Sobrin; Margaret Parker; Soumya Raychaudhuri; Perciliz L Tan; Edwin C Oh; Joanna E Merriam; Eric Souied; Paul S Bernstein; Binxing Li; Jeanne M Frederick; Kang Zhang; Milam A Brantley; Aaron Y Lee; Donald J Zack; Betsy Campochiaro; Peter Campochiaro; Stephan Ripke; R Theodore Smith; Gaetano R Barile; Nicholas Katsanis; Rando Allikmets; Mark J Daly; Johanna M Seddon
Journal:  Proc Natl Acad Sci U S A       Date:  2010-04-12       Impact factor: 11.205

4.  Metabolism of complement factor D in renal failure.

Authors:  M Pascual; G Steiger; J Estreicher; K Macon; J E Volanakis; J A Schifferli
Journal:  Kidney Int       Date:  1988-10       Impact factor: 10.612

5.  Quantitation of complement factor D in human serum by a solid-phase radioimmunoassay.

Authors:  S R Barnum; M A Niemann; J F Kearney; J E Volanakis
Journal:  J Immunol Methods       Date:  1984-03-16       Impact factor: 2.303

Review 6.  The pivotal role of the complement system in aging and age-related macular degeneration: hypothesis re-visited.

Authors:  Don H Anderson; Monte J Radeke; Natasha B Gallo; Ethan A Chapin; Patrick T Johnson; Christy R Curletti; Lisa S Hancox; Jane Hu; Jessica N Ebright; Goldis Malek; Michael A Hauser; Catherine Bowes Rickman; Dean Bok; Gregory S Hageman; Lincoln V Johnson
Journal:  Prog Retin Eye Res       Date:  2009-12-02       Impact factor: 21.198

7.  Human adipsin is identical to complement factor D and is expressed at high levels in adipose tissue.

Authors:  R T White; D Damm; N Hancock; B S Rosen; B B Lowell; P Usher; J S Flier; B M Spiegelman
Journal:  J Biol Chem       Date:  1992-05-05       Impact factor: 5.157

Review 8.  The adipocyte as an endocrine cell.

Authors:  J L Miner
Journal:  J Anim Sci       Date:  2004-03       Impact factor: 3.159

9.  Mechanism of action of factor D of the alternative complement pathway.

Authors:  P H Lesavre; H J Müller-Eberhard
Journal:  J Exp Med       Date:  1978-12-01       Impact factor: 14.307

10.  Assembly of the cytolytic alternative pathway of complement from 11 isolated plasma proteins.

Authors:  R D Schreiber; H J Müller-Eberhard
Journal:  J Exp Med       Date:  1978-12-01       Impact factor: 14.307

View more
  35 in total

1.  Inhibiting alternative pathway complement activation by targeting the factor D exosite.

Authors:  Kenneth J Katschke; Ping Wu; Rajkumar Ganesan; Robert F Kelley; Mary A Mathieu; Philip E Hass; Jeremy Murray; Daniel Kirchhofer; Christian Wiesmann; Menno van Lookeren Campagne
Journal:  J Biol Chem       Date:  2012-02-23       Impact factor: 5.157

Review 2.  Genome-wide association studies: getting to pathogenesis, the role of inflammation/complement in age-related macular degeneration.

Authors:  Jessica N Cooke Bailey; Margaret A Pericak-Vance; Jonathan L Haines
Journal:  Cold Spring Harb Perspect Med       Date:  2014-09-11       Impact factor: 6.915

3.  Inhibitors of factor d may provide a treatment for age-related macular degeneration.

Authors:  Ahmed F Abdel-Magid
Journal:  ACS Med Chem Lett       Date:  2014-01-30       Impact factor: 4.345

Review 4.  Risk factors and biomarkers of age-related macular degeneration.

Authors:  Nathan G Lambert; Hanan ElShelmani; Malkit K Singh; Fiona C Mansergh; Michael A Wride; Maximilian Padilla; David Keegan; Ruth E Hogg; Balamurali K Ambati
Journal:  Prog Retin Eye Res       Date:  2016-05-06       Impact factor: 21.198

Review 5.  Modern Therapeutic Approaches for Noninfectious Ocular Diseases Involving Inflammation.

Authors:  Michelle L Ratay; Elena Bellotti; Riccardo Gottardi; Steven R Little
Journal:  Adv Healthc Mater       Date:  2017-10-16       Impact factor: 9.933

Review 6.  Genetic Determination of Serum Levels of Diabetes-Associated Adipokines.

Authors:  Dorit Schleinitz
Journal:  Rev Diabet Stud       Date:  2016-01-28

7.  Correlation of neutrophil/lymphocyte and platelet/lymphocyte ratio with visual acuity and macular thickness in age-related macular degeneration.

Authors:  Elvan Alper Sengul; Ozgur Artunay; Alev Kockar; Ceyda Afacan; Rifat Rasier; Palmet Gun; Nazli Gul Yalcin; Erdal Yuzbasioglu
Journal:  Int J Ophthalmol       Date:  2017-05-18       Impact factor: 1.779

Review 8.  Complement Activation and Inhibition in Retinal Diseases.

Authors:  Mark E Kleinman; Jayakrishna Ambati
Journal:  Dev Ophthalmol       Date:  2015-10-26

Review 9.  Applying complement therapeutics to rare diseases.

Authors:  Edimara S Reis; Dimitrios C Mastellos; Despina Yancopoulou; Antonio M Risitano; Daniel Ricklin; John D Lambris
Journal:  Clin Immunol       Date:  2015-09-01       Impact factor: 3.969

10.  Plasma levels of complement proteins from the alternative pathway in patients with age-related macular degeneration are independent of Complement Factor H Tyr⁴⁰²His polymorphism.

Authors:  Aldacilene Souza Silva; Anderson Gustavo Teixeira; Lorena Bavia; Fabio Lin; Roberta Velletri; Rubens Belfort; Lourdes Isaac
Journal:  Mol Vis       Date:  2012-08-30       Impact factor: 2.367

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.